Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

RGNX REGENXBIO PE ratio, current and historical analysis

The current PE ratio of RGNX can't be determined, as the TTM EPS of -$3.1 is negative. The last PE ratio of REGENXBIO, recorded in September 2022, was 14.52.

RGNX PE ratio history

How has RGNX's PE ratio performed in the past

The PE ratio of REGENXBIO has averaged 17.2 over the last nine years. Over the past nine years, RGNX's PE ratio was at its highest in the Sep 2018 quarter at 29.49, when the stock price was $75.5 and the EPS was $2.56. The lowest value was in the Dec 2021 quarter, when it reached 10.86 with a price of $32.7 and an EPS of $3.01.

Today
N/A
Average
17.2
Median
14.28
Minimum
10.86
Maximum
29.49

REGENXBIO PE ratio by year

Year PE ratio PE change Price EPS
2024 N/A N/A $7.73 -$4.59
2023 N/A N/A $17.95 -$6.02
2022 N/A N/A $22.68 -$6.5
2021 10.86 N/A $32.7 $3.01
2020 N/A N/A $45.36 -$2.98
2019 N/A N/A $40.97 -$2.58
2018 14.03 N/A $41.95 $2.99
2017 N/A N/A $33.25 -$2.45
2016 N/A N/A $18.55 -$2.38
2015 N/A N/A $16.6 -$2.59
2014 N/A N/A N/A -$1.82
2013 N/A N/A N/A -$2.5

REGENXBIO PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2025 N/A N/A $7.15 -$3.1
Dec 2024 N/A N/A $7.73 -$4.59
Sep 2024 N/A N/A $10.49 -$5.02
Jun 2024 N/A N/A $11.7 -$5.26
Mar 2024 N/A N/A $21.07 -$5.87
Dec 2023 N/A N/A $17.95 -$6.02
Sep 2023 N/A N/A $16.46 -$5.99
Jun 2023 N/A N/A $19.99 -$6.33
Mar 2023 N/A N/A $18.91 -$6.25
Dec 2022 N/A N/A $22.68 -$6.5
Sep 2022 14.52 29.3% $26.43 $1.82
Jun 2022 11.23 -18.09% $24.7 $2.2
Mar 2022 13.71 26.24% $33.19 $2.42
Dec 2021 10.86 N/A $32.7 $3.01
Sep 2021 N/A N/A $41.92 -$5.16

RGNX Price vs fair value

How does RGNX's price compare to its estimated fair value based on its growth

RGNX average PE ratio chart

What is the average PE ratio of RGNX for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

RGNX PE vs peers

What is RGNX's PE ratio compared to its peers
Stock name PE ratio Market cap
OLMA Olema Pharmaceuticals Inc N/A $304.13M
OMER Omeros Corp N/A $215.91M
VIVS VivoSim Labs Inc. N/A $2.68M
ORIC Oric Pharmaceuticals Inc N/A $690.98M
ORMP Oramed Pharmaceuticals Inc N/A $88.24M
RGNX REGENXBIO Inc N/A $477.02M

Frequently asked questions

What is REGENXBIO's PE ratio?

The current price to earnings ratio of RGNX can't be calculated, as its EPS of -$3.1 is negative.

What is the highest PE ratio for RGNX?

Over the last nine years, the quarterly PE ratio reached a historic high of 29.49 in the Sep 2018 quarter.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.